| Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections JL Liscio, MV Mahoney, EB Hirsch International journal of antimicrobial agents 46 (3), 266-271, 2015 | 115 | 2015 |
| Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft‐Gault and modification of diet in renal disease MV Golik, KR Lawrence Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (9 …, 2008 | 86 | 2008 |
| Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens E Walker, A Lyman, K Gupta, MV Mahoney, GM Snyder, EB Hirsch Clinical Infectious Diseases 63 (7), 960-965, 2016 | 61 | 2016 |
| Assessment of fosfomycin for complicated or multidrug-resistant urinary tract infections: patient characteristics and outcomes SE Giancola, MV Mahoney, MD Hogan, BR Raux, C McCoy, EB Hirsch Chemotherapy 62 (2), 100-104, 2017 | 28 | 2017 |
| Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile CD Alonso, MV Mahoney Infection and drug resistance 12, 1, 2019 | 21 | 2019 |
| The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections KR Lawrence, MV Golik, L Davidson American journal of therapeutics 16 (4), 333-338, 2009 | 20 | 2009 |
| Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections SE Giancola, MV Mahoney, TE Bias, EB Hirsch Therapeutics and clinical risk management 12, 787, 2016 | 19 | 2016 |
| Update on treatment options for gonococcal infections JW Lancaster, MV Mahoney, S Mandal, KR Lawrence Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (9 …, 2015 | 17 | 2015 |
| Treatment of enterococcal peritonitis with intraperitoneal daptomycin in a vancomycin-allergic patient and a review of the literature JF Gilmore, M Kim, MT LaSalvia, MVG Mahoney Peritoneal Dialysis International 33 (4), 353-357, 2013 | 15 | 2013 |
| Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence? RW Chapin, T Lee, C McCoy, CD Alonso, MV Mahoney Annals of Pharmacotherapy 51 (9), 804-810, 2017 | 14 | 2017 |
| Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection? MT LaSalvia, W Branch-Elliman, GM Snyder, MV Mahoney, CD Alonso, ... Open forum infectious diseases 4 (1), ofw264, 2017 | 14 | 2017 |
| Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia LR Biehle, JM Cottreau, DJ Thompson, RL Filipek, JN O’Donnell, ... PloS one 10 (11), e0143845, 2015 | 14 | 2015 |
| Eravacycline: the tetracyclines strike back M Heaney, MV Mahoney, JC Gallagher Annals of Pharmacotherapy 53 (11), 1124-1135, 2019 | 12 | 2019 |
| Pharmacists’ familiarity with and institutional utilization of rapid diagnostic technologies for antimicrobial stewardship RA Foster, K Kuper, ZK Lu, PB Bookstaver, CM Bland, MV Mahoney infection control & hospital epidemiology 38 (7), 863-866, 2017 | 9 | 2017 |
| Interplay between rapid diagnostic tests and antimicrobial stewardship programs among patients with bloodstream and other severe infections M Beganovic, EK McCreary, MV Mahoney, B Dionne, DA Green, ... The journal of applied laboratory medicine 3 (4), 601-616, 2019 | 7 | 2019 |
| Does the beta-lactam matter? Nafcillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bloodstream infections CC Burrelli, EK Broadbent, A Margulis, GM Snyder, HS Gold, C McCoy, ... Chemotherapy 63 (6), 345-351, 2018 | 5 | 2018 |
| Nasal methicillin-resistant Staphylococcus aureus screening in patients with pneumonia: a powerful antimicrobial stewardship tool EA Smith, HS Gold, MV Mahoney, EB Hirsch, SE Giancola, GM Snyder, ... American journal of infection control 45 (11), 1295-1296, 2017 | 5 | 2017 |
| Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients … N Permpalung, MV Mahoney, C McCoy, A Atsawarungruangkit, HS Gold, ... Leukemia & lymphoma 60 (1), 85-91, 2019 | 4 | 2019 |
| Recent developments in the management of recurrent Clostridioides difficile infection R Mendo-Lopez, J Villafuerte-Gálvez, N White, MV Mahoney, CP Kelly, ... Anaerobe 62, 102108, 2020 | 3 | 2020 |
| Adjunctive use of cidofovir and intravenous immunoglobulin to treat invasive adenoviral disease in solid organ transplant recipients N Permpalung, MV Mahoney, CD Alonso Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (12 …, 2018 | 3 | 2018 |
